Monza – Eight defendants indicted, three acquittal rulings, one non-prosecution, a plea deal, and 120 workers accepted as civil parties. These are the numbers of the hearing held on Monday before the investigating judge of the Monza court [in the photo on the right] Licinia Petrella, in the bis trial for the bankruptcy of XPharma, the pharmaceutical company of Agrate declared bankrupt in 2009 with debts of over twenty million euros. Among the accused, there are also Thomas Shomaker, 55, Thomas Hubert Gotzmann, 45, and Georg Leonhart Nagl, 45, the first two directors of X Pharma and of the parent company Pharmexx Italia; the third considered the creator of the mechanism according to which X Pharma would have been nothing more than a 'container' to dispose of redundant manpower from multinationals in the pharmaceutical sector.
The Agrate company, in fact, had been created without a concrete business plan. Originally there was a sale of the company branch, carried out by taking personnel from multinationals (Merck Sharp & Dohme, Italia spa, Solvay, Fournier). For the X Pharma case, in December 2009 the
